HOME          ABOUT ERC          RESEARCHERS          FUNDERS         ELC               Join/Log In
ERC








Research
New Therapy Commercialization Grants Program
The Epilepsy Foundation - New Therapy Commercialization Grants Program supports the development of more effective therapies by serving as a catalyst for moving innovative therapies from the laboratory to the patient. Investigators must hold a relevant advanced degree (M.D., and/or Ph.D.), and have completed all research training. This call for proposals is open to investigators at corporations as well as the academic/university arena.

The mission of the Epilepsy Foundation - New Therapy Commercialization Grants Program is to drive the development of new therapies for epilepsy, accelerating the advancement of research from the laboratory to the patient. The Foundation funds innovative senior level research projects led by the nation's leading scientists with the potential to discover new treatment options and ultimately a cure.
Opportunity Contact:
grants administrator   
Dates LOI Dates

Open: 12/28/17
Close: 2/1/18
Response: 3/16/18
Dates Application Dates

Open: 3/19/18
Close: 4/20/18
Response: 6/29/18
Funding Level: $350,000
Funding Length: 24 months
Funding Start Date: 7/1/18
 
Please enter your email address below. If you are already a member you will be logged in. If you are not a current member, you will be registered automatically.


The email address you entered is associated with an existing account.